15/11/2026
2 years of TTC. Recurrent early pregnancy losses. And countless unanswered questions.
For this couple, the challenge was not simply achieving pregnancy, but maintaining it.
At 33, this patient and her partner turned to Fertilysis, hoping to understand what might have been overlooked and approach their next pregnancy with a clearer plan.
In March 2026, a comprehensive reproductive assessment explored male fertility, including s***m DNA fragmentation, the female reproductive tract microbiome and reproductive immunology.
The investigations identified anaerobic dysbiosis within the female reproductive tract, alongside an altered reproductive immune profile characterised by an elevated Th1/Th2 cytokine ratio and a negative LAD test. Considered alongside their clinical history, these findings informed a personalised treatment plan. Their care included diagnostic hysteroscopy, 5 uterine antibiotic washes and oral antibiotics for chronic endometritis, two sessions of lymphocyte immunotherapy (LIT), and continued reproductive immunology care and support.
In June 2026, they had a positive pregnancy test. Importantly, the pregnancy occurred spontaneously, without IVF or embryo transfer.
After 2 years of secondary infertility and previous early miscarriages, this represented an important new chapter in the couple’s fertility journey. Today, the pregnancy continues to progress, and they are looking forward to welcoming their baby girl in early 2027. 🤍
“Our long-awaited second pregnancy finally became a reality, and Fertilysis will always hold a special place in our story.”
Their story highlights the importance of looking beyond standard testing when recurrent pregnancy loss remains unexplained, interpreting findings within the full clinical picture and providing individualised care along the way.
Thank you for trusting Fertilysis with your care. We are so pleased to share this special chapter with you. 🫂